BioProtect

Tzur Yigal, Israel · Founded 2004 · Acquired/Merged (Operating Subsidiary)

Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. BioProtect is based in Tzur Yigal, Israel and was founded in 2004. Its last known valuation is $200 million (Jan 2026). It has raised $67.9 million.

Last price · $/share
—
Implied valuation
$200.0M
Total raised
$67.9M
Last round
—

Who backs BioProtect?

21 investors
InvestorType
KB InvestmentVenture capital
Innovation AuthorityOther
Peregrine VenturesVenture capital
Consensus Business GroupFund of funds
Vincent TchenguizOther
AJJS Holdings—
Almeda Ventures—
Aran Research Development & Prototypes—
EarlyCap—
European Innovation Council (Belgium)—
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioProtect investors

21 investors are on record for BioProtect, including KB Investment, Innovation Authority, Peregrine Ventures and Consensus Business Group.

Free account
More of BioProtect with a free account
  • ·The complete investor list: 21 names
  • ·Watch BioProtect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like BioProtect. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View